Pfizer Leadership and Structure
Pfizer's Executive Leadership Team is the company's senior-most leadership and decision-making management body. It brings together our top leaders to focus on major financial, strategic and operational decisions for the company.
Worldwide Research and Development at Pfizer combines research and technology units that have deep disease area expertise and cutting-edge science and platforms with an efficient R&D operating model, to discover and develop innovative therapeutic programs in small molecules and biotherapeutics, including vaccines.
Our new commercial operating structure represents the next step in Pfizer's journey to further revitalize our innovative core, enhance the value of our consumer and off-patent established brands, and maximize the use of our capital to deliver value to patients and our shareholders. Through this evolution, we are enabling greater independence, focus and responsiveness for our businesses.
With this structure, we are able to rapidly capitalize on opportunities to advance our business by increasing support for successful new medicines, forging partnerships with key customers, entering into co-promotion and licensing agreements, investing in new technologies to add value to our core product offerings, and acquiring new products and services from outside the company.